BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27605259)

  • 1. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
    Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study.
    González HE; Martínez JR; Vargas-Salas S; Solar A; Veliz L; Cruz F; Arias T; Loyola S; Horvath E; Tala H; Traipe E; Meneses M; Marín L; Wohllk N; Diaz RE; Véliz J; Pineda P; Arroyo P; Mena N; Bracamonte M; Miranda G; Bruce E; Urra S
    Thyroid; 2017 Aug; 27(8):1058-1067. PubMed ID: 28521616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology.
    Kloos RT; Monroe RJ; Traweek ST; Lanman RB; Kennedy GC
    Thyroid; 2016 Jun; 26(6):785-93. PubMed ID: 26992356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-Needle Aspiration with Immunohistochemistry Using a Modified Scrape Cell Block Technique for the Diagnosis of Thyroid and Parathyroid Nodules.
    Wuertz FG; Kresnik E; Malle P; Hyden M; Lind P; Rogatsch H; Gallowitsch HJ
    Acta Cytol; 2016; 60(2):118-30. PubMed ID: 27231232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier.
    Randolph GW; Sosa JA; Hao Y; Angell TE; Shonka DC; LiVolsi VA; Ladenson PW; Blevins TC; Duh QY; Ghossein R; Harrell M; Patel KN; Shanik MH; Traweek ST; Walsh PS; Yeh MW; Abdelhamid Ahmed AH; Ho AS; Wong RJ; Klopper JP; Huang J; Kennedy GC; Kloos RT; Sadow PM
    Thyroid; 2022 Sep; 32(9):1069-1076. PubMed ID: 35793115
    [No Abstract]   [Full Text] [Related]  

  • 6. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.
    Suzuki A; Hirokawa M; Takada N; Higuchi M; Ito A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2017 Nov; 64(11):1099-1104. PubMed ID: 28883261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics for the diagnosis of thyroid lesions: preliminary report.
    Pagni F; Mainini V; Garancini M; Bono F; Vanzati A; Giardini V; Scardilli M; Goffredo P; Smith AJ; Galli M; De Sio G; Magni F
    Cytopathology; 2015 Oct; 26(5):318-24. PubMed ID: 25040579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
    J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears.
    Titov SE; Demenkov PS; Ivanov MK; Malakhina ES; Poloz TL; Tsivlikova EV; Ganzha MS; Shevchenko SP; Gulyaeva LF; Kolesnikov NN
    Oncol Rep; 2016 Nov; 36(5):2501-2510. PubMed ID: 27666315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
    Trimboli P; Guidobaldi L; Bongiovanni M; Crescenzi A; Alevizaki M; Giovanella L
    Diagn Cytopathol; 2016 Jan; 44(1):45-51. PubMed ID: 26481456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.
    Patel KN; Angell TE; Babiarz J; Barth NM; Blevins T; Duh QY; Ghossein RA; Harrell RM; Huang J; Kennedy GC; Kim SY; Kloos RT; LiVolsi VA; Randolph GW; Sadow PM; Shanik MH; Sosa JA; Traweek ST; Walsh PS; Whitney D; Yeh MW; Ladenson PW
    JAMA Surg; 2018 Sep; 153(9):817-824. PubMed ID: 29799911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
    Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
    Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma.
    El Naofal M; Kim A; Yon HY; Baity M; Ming Z; Bui-Griffith J; Tang Z; Robinson M; Grubbs EG; Cote GJ; Hu P
    Ann Clin Lab Sci; 2017 Sep; 47(5):523-528. PubMed ID: 29066476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Serum Calcitonin in Patients Without a Suspicious History of Medullary Thyroid Carcinoma and with Thyroid Nodules Without an Indication for Fine-Needle Aspiration or with Benign Cytology.
    Rosario PW; Calsolari MR
    Horm Metab Res; 2016 Jun; 48(6):372-276. PubMed ID: 27203410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules.
    Walsh PS; Wilde JI; Tom EY; Reynolds JD; Chen DC; Chudova DI; Pagan M; Pankratz DG; Wong M; Veitch J; Friedman L; Monroe R; Steward DL; Lupo MA; Lanman RB; Kennedy GC
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2297-306. PubMed ID: 23087323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical and clinical validation of pairwise microRNA expression analysis to identify medullary thyroid cancer in thyroid fine-needle aspiration samples.
    Ciarletto AM; Narick C; Malchoff CD; Massoll NA; Labourier E; Haugh K; Mireskandari A; Finkelstein SD; Kumar G
    Cancer Cytopathol; 2021 Mar; 129(3):239-249. PubMed ID: 33017868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
    Nikiforova MN; Mercurio S; Wald AI; Barbi de Moura M; Callenberg K; Santana-Santos L; Gooding WE; Yip L; Ferris RL; Nikiforov YE
    Cancer; 2018 Apr; 124(8):1682-1690. PubMed ID: 29345728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: A case report and review of the literatures.
    Liu Y; Yuan L; Yang D; Jin Y
    Diagn Cytopathol; 2018 Aug; 46(8):690-693. PubMed ID: 29524315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.
    Giovanella L; Imperiali M; Piccardo A; Taborelli M; Verburg FA; Daurizio F; Trimboli P
    Eur J Clin Invest; 2018 Jun; 48(6):e12934. PubMed ID: 29635700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.